Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Top Dev Biol ; 94: 77-127, 2011.
Article in English | MEDLINE | ID: mdl-21295685

ABSTRACT

Neuroblastoma (NB), the most common extracranial solid tumor in childhood, is an extremely heterogeneous disease both biologically and clinically. Although significant progress has been made in identifying molecular and genetic markers for NB, this disease remains an enigmatic challenge. Since NB is thought to be an embryonal tumor that is derived from precursor cells of the peripheral (sympathetic) nervous system, understanding the development of normal sympathetic nervous system may highlight abnormal events that contribute to NB initiation. Therefore, this review focuses on the development of the peripheral trunk neural crest, the current understanding of how developmental factors may contribute to NB and on recent advances in the identification of important genetic lesions and signaling pathways involved in NB tumorigenesis and metastasis. Finally, we discuss how future advances in identification of molecular alterations in NB may lead to more effective, less toxic therapies, and improve the prognosis for NB patients.


Subject(s)
Neural Crest/metabolism , Neuroblastoma/metabolism , Animals , Apoptosis , Humans , Intercellular Signaling Peptides and Proteins/metabolism , MicroRNAs/genetics , Nerve Growth Factors/metabolism , Neural Crest/cytology , Neuroblastoma/genetics , Neuroblastoma/pathology , Neuroblastoma/therapy
2.
Biochim Biophys Acta ; 1783(6): 1055-67, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18342014

ABSTRACT

Caspase-8 is frequently deleted or silenced in neuroblastoma and other solid tumor such as medulloblastoma and small cell lung carcinoma. Caspase-8 expression can be re-established in neuroblastoma cell lines by treatment with demethylating agents or with IFN-gamma. Here we show that four different retinoic acid (RA) derivatives also increase caspase-8 protein expression in neuroblastoma, medulloblastoma and small cell lung carcinoma cell lines. This increase in protein expression is mirrored by an increase in RNA expression in NB cells. However, the promoter region of the caspase-8 gene was not responsible for the induction of caspase-8 expression. Rather, we identified another intronic region containing a CREB binding site that was required for maximal induction of caspase-8 via RA. DNA-protein interaction assays revealed increased phospho-CREB binding to this response element in RA-treated NB cells. Furthermore, mutations of the CREB binding site completely blocked caspase-8 induction in the luciferase reporter system assay and transfection of dominant-negative form of CREB repressed the up-regulation of caspase-8 by RA. Importantly, RA-released cells maintained caspase-8 expression for at least 2-5 days and were more sensitive to doxorubicin and TNFalpha. Thus, RA treatment in conjunction with TNFalpha and/or subsets of cytotoxic agents may have therapeutic benefits.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Caspase 8/genetics , Cyclic AMP Response Element-Binding Protein/metabolism , Neuroblastoma/pathology , Transcription, Genetic , Tretinoin/pharmacology , Antibiotics, Antineoplastic/pharmacology , Apoptosis/physiology , Blotting, Western , Carcinoma, Small Cell/drug therapy , Carcinoma, Small Cell/genetics , Carcinoma, Small Cell/pathology , Caspase 8/metabolism , Cell Proliferation/drug effects , Chromatin Immunoprecipitation , Cyclic AMP Response Element-Binding Protein/genetics , DNA Methylation , Doxorubicin/pharmacology , Electrophoretic Mobility Shift Assay , Humans , Introns/genetics , Luciferases/metabolism , Lung Neoplasms/drug therapy , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Medulloblastoma/drug therapy , Medulloblastoma/genetics , Medulloblastoma/pathology , Mutation/genetics , Neuroblastoma/drug therapy , Neuroblastoma/genetics , Phosphorylation/drug effects , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Messenger/metabolism , Response Elements/genetics , Signal Transduction , Transcriptional Activation , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/pharmacology
3.
J Mol Biol ; 341(1): 271-9, 2004 Jul 30.
Article in English | MEDLINE | ID: mdl-15312778

ABSTRACT

Proteomics was used to identify a protein encoded by ORF 3a in a SARS-associated coronavirus (SARS-CoV). Immuno-blotting revealed that interchain disulfide bonds might be formed between this protein and the spike protein. ELISA indicated that sera from SARS patients have significant positive reactions with synthesized peptides derived from the 3a protein. These results are concordant with that of a spike protein-derived peptide. A tendency exists for co-mutation between the 3a protein and the spike protein of SARS-CoV isolates, suggesting that the function of the 3a protein correlates with the spike protein. Taken together, the 3a protein might be tightly correlated to the spike protein in the SARS-CoV functions. The 3a protein may serve as a new clinical marker or drug target for SARS treatment.


Subject(s)
Severe acute respiratory syndrome-related coronavirus/metabolism , Viral Proteins/metabolism , Animals , Chlorocebus aethiops , Disulfides/metabolism , Humans , Membrane Glycoproteins/metabolism , Phylogeny , Proteomics , Severe acute respiratory syndrome-related coronavirus/chemistry , Severe acute respiratory syndrome-related coronavirus/genetics , Sequence Analysis, Protein , Spike Glycoprotein, Coronavirus , Vero Cells , Viral Envelope Proteins/metabolism , Viral Proteins/chemistry , Viral Proteins/genetics , Viroporin Proteins
4.
Bioorg Med Chem Lett ; 14(11): 2781-5, 2004 Jun 07.
Article in English | MEDLINE | ID: mdl-15125932

ABSTRACT

Four analogs of OSW-1 (1-4) with modified side chains on the steroidal skeleton were synthesized following modification of our previous route for the total synthesis of OSW-1. Testing of the analogs against growth of tumor cells demonstrated that the 22-one function and the full length of the side chain of OSW-1 were not required for the antitumor action of OSW-1.


Subject(s)
Antineoplastic Agents/chemical synthesis , Cholestenones/pharmacology , Saponins/pharmacology , Antineoplastic Agents/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Cholestenones/chemical synthesis , Drug Design , Drug Screening Assays, Antitumor , Humans , Inhibitory Concentration 50 , Saponins/chemical synthesis , Structure-Activity Relationship
5.
Mol Cell Proteomics ; 3(1): 73-81, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14593079

ABSTRACT

To better understand the mechanism underlying the hepatocellular carcinoma (HCC) metastasis and to search potential markers for HCC prognosis, differential proteomic analysis on two well-established HCC cell strains with high and low metastatic potentials, MHCC97-H and MHCC97-L, was conducted using two-dimensional gel electrophoresis followed by matrix-assisted laser desorption/time-of-flight mass spectrometry. Cytokeratin 19 (CK19) was identified and found to be overexpressed in MHCC97-H as compared with MHCC97-L. This result was further confirmed by two-dimensional Western blot analysis and immunofluorescence assay. Furthermore, one-dimensional Western blot analysis showed consistently increased CK19 expression in progressively more metastatic cells. Immunohistochemical study on 102 human HCC specimens revealed that more patients in the CK19-positive group had overt intrahepatic metastases (satellite nodules, p < 0.05; vascular tumor emboli, p < 0.001; tumor node metastatis staging, p < 0.001). CK19 fragment CYFRA 21-1 levels measured in sera from nude mice model of human HCC metastasis with radioimmunoassay increased in parallel with tumor progression and rose remarkably when pulmonary metastases occurred. The results demonstrated that overexpression of CK19 in HCC cells is related to metastatic behavior. Serum CK19 level might reflect the pathological progression in some HCC and may be a useful marker for predicting tumor metastasis and a therapeutic target for the treatment of HCC patients with metastases.


Subject(s)
Carcinoma, Hepatocellular/metabolism , Keratins/metabolism , Liver Neoplasms/metabolism , Proteome/analysis , Animals , Biomarkers, Tumor , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Electrophoresis, Gel, Two-Dimensional , Humans , Keratins/genetics , Liver Neoplasms/diagnosis , Liver Neoplasms/pathology , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Metastasis , Peptide Fragments/genetics , Peptide Fragments/metabolism , Random Allocation , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
6.
Oncogene ; 22(21): 3252-9, 2003 May 22.
Article in English | MEDLINE | ID: mdl-12761495

ABSTRACT

Although tripchlorolide (TC), a compound purified from a Chinese herb Tripterygium Wilfordii Hook, has been demonstrated to be a potent antitumor agent, its mechanisms of action are unknown. The present study shows that TC induces apoptosis of Chinese Hamster Ovary (CHO) cells. Most strikingly, TC was particularly potent in inducing apoptosis of the UV41 mutant CHO cells, which are deficient in the ERCC4 gene encoding a nucleotide excision repair protein. TC caused a higher level of DNA damage in UV41 cells than those in the wild-type CHO cells or EM9 cells, which are deficient in single-strand break repair. These results provided a critical link between apoptotic hypersensitivity and DNA damage in defective nucleotide excision repair pathway of UV41 cells by TC treatment. Further analysis showed that degradation of the c-Myc protein in TC-treated UV41 cells was much stronger than those in the wild-type CHOAA8 and the EM9. A proteasome inhibitor, MG132, reduced both the degradation of c-Myc and apoptosis in TC-treated UV41 cells. Expression of exogenous c-Myc also inhibited apoptosis of TC-treated UV41 cells. These results indicate that c-Myc degradation induced by DNA damage in the presence of TC contributes to induction of apoptosis of UV41 cells.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , DNA Damage , Diterpenes/pharmacology , Phenanthrenes , Proto-Oncogene Proteins c-myc/metabolism , Animals , CHO Cells , Cricetinae , Cysteine Endopeptidases/metabolism , Multienzyme Complexes/metabolism , Proteasome Endopeptidase Complex , Ubiquitin/metabolism
7.
J Biol Chem ; 278(13): 11561-9, 2003 Mar 28.
Article in English | MEDLINE | ID: mdl-12538586

ABSTRACT

Lipid rafts/caveolae are found to be essential for insulin-like growth factor (IGF)-1 receptor signaling during 3T3-L1 preadipocyte differentiation induction. In 3T3-L1 cells, IGF-1 receptor is located in lipid rafts/caveolae of the plasma membrane and can directly interact with caveolin-1, the major protein component in caveolae. Disruption of lipid rafts/caveolae by depleting cellular cholesterol with cholesterol-binding reagent, beta-methylcyclodextrin or filipin, blocks the IGF-1 receptor signaling in 3T3-L1 preadipocyte. Both hormonal induced adipocyte differentiation and mitotic clonal expansion are inhibited by lipid rafts/caveolae disruption. However, a nonspecific lipid binding reagent, xylazine, does not affect adipocyte differentiation or mitotic clonal expansion. Further studies indicate that lipid rafts/caveolae are required only for IGF-1 receptor downstream signaling and not the activation of receptor itself by ligand. Thus, our results suggest that localization in lipid rafts/caveolae and association with caveolin enable IGF-1 receptor to have a close contact with downstream signal molecules recruited into lipid rafts/caveolae and transmit the signal through these signal molecule complexes.


Subject(s)
Adipocytes/cytology , Caveolae/physiology , Cell Differentiation/physiology , Lipids/physiology , Receptor, IGF Type 1/metabolism , Signal Transduction , 3T3 Cells , Animals , Cholesterol/metabolism , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...